John Werning, MD
Otolaryngology · Maumee, OHNPI 1255358032
Payments from drug & device makers
What this record shows
Inspire Medical Systems, Inc. accounts for 89.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $1,749 and has fallen 90.0% since, to $174 in 2025.
Across 27 payments — averaging $83.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Integra Lifesciences Corporation$38
- Aerin Medical Inc.$37
- Stryker$28
- Optinose US, Inc.$21
- Smith+Nephew$21
- plus $89 from 5 others
What the payments were for
- Travel & lodging$92541%
- Food & beverage$1,32059%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 15 | $2,011 |
| Integra Lifesciences Corporation | 2 | $38 |
| Aerin Medical Inc. | 1 | $37 |
| Stryker | 2 | $28 |
| Optinose US, Inc. | 1 | $21 |
| Smith+Nephew | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $20 |
| GSK | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Kls-martin L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,245 in reported general payments places this provider in the 65th percentile of 380 otolaryngology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 128 | $1,152 |
| Ipratropium Bromide | 36 | $810 |
| Pantoprazole Sodium | 77 | $724 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $231 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $138 |
| Levothyroxine Sodium | 13 | $93 |
| Famotidine | 17 | $89 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Maumee
- Raj SindwaniCleveland$598K
- Mark MehleCleveland$403K
- Troy WoodardCleveland$392K
- Oliver AdunkaColumbus$338K
- Subinoy DasColumbus$142K
- Sanjeet RangarajanCleveland$113K
- Sumit BapnaDublin$95K
- Boris KaranfilovDublin$82K
- Alexander DonathCincinnati$64K
- Rod RezaeeCleveland$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.